Skip to content
healthcare.dev

DROXIA

NDC 80725-830, Hydroxyurea, capsule, from Waylis Therapeutics LLC.

Product NDC
80725-830
Status
Listed
Labeler
Waylis Therapeutics LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA016295
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/80725-830 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDROXYUREA300 mg/1

Pharmacologic classes

Antimetabolite [EPC]; Urea [CS]

Package NDCNDC-11Package
80725-830-608072508306060 CAPSULE in 1 BOTTLE (80725-830-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4ad13dc6-a2ab-4308-96b3-7c642c92cc23

Use it

Look up 80725-830 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/80725-830 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 80725-830. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.